Skip to main content
placeholder image

Phase II trial of rhIL-6 (interleukin-6) prior to and concurrently with VAD (vincristine, doxorubicin and dexamethasone) chemotherapy for patients with multiple myeloma

Journal Article


Abstract


Publication Date


  • 1997

Citation


  • Young, R. I., Ranson, M., Chang, J., Lord, B., Testa, N., & Scarffe, J. H. (1997). Phase II trial of rhIL-6 (interleukin-6) prior to and concurrently with VAD (vincristine, doxorubicin and dexamethasone) chemotherapy for patients with multiple myeloma. EUROPEAN JOURNAL OF CANCER, 33(2), 307-311. doi:10.1016/S0959-8049(96)00383-8

Number Of Pages


  • 5

Start Page


  • 307

End Page


  • 311

Volume


  • 33

Issue


  • 2

Abstract


Publication Date


  • 1997

Citation


  • Young, R. I., Ranson, M., Chang, J., Lord, B., Testa, N., & Scarffe, J. H. (1997). Phase II trial of rhIL-6 (interleukin-6) prior to and concurrently with VAD (vincristine, doxorubicin and dexamethasone) chemotherapy for patients with multiple myeloma. EUROPEAN JOURNAL OF CANCER, 33(2), 307-311. doi:10.1016/S0959-8049(96)00383-8

Number Of Pages


  • 5

Start Page


  • 307

End Page


  • 311

Volume


  • 33

Issue


  • 2